Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.16% |
| 2 | Healthcare | 9.53% |
| 3 | Financials | 9.25% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
CapForce IBD 50 ETF
FFTY
$78.8M
| $285K | ﹤0.01% |
7,401
+3,584
| +94% | +$132K |
|
5177
Spyre Therapeutics
SYRE
$9.19B
| $285K | ﹤0.01% |
1,193
-419
| -26% | -$97.9K |
|
|
UBFO
5178
DELISTED
United Security Bancshares
UBFO
| $285K | ﹤0.01% |
25,718
-6,241
| -20% | -$68.9K |
|
|
IOTS
5179
DELISTED
Adesto Technologies Corp
IOTS
| $285K | ﹤0.01% |
47,849
+5,342
| +13% | +$31.8K |
|
|
CMTA
5180
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $285K | ﹤0.01% |
25,573
-13,857
| -35% | -$146K |
|
|
CBB.PRB
5181
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
| $285K | ﹤0.01% |
5,801
-527
| -8% | -$26K |
|
5182
Kopin
KOPN
$788M
| $284K | ﹤0.01% |
117,273
-36,071
| -24% | -$91.6K |
|
|
MSD
5183
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
| $284K | ﹤0.01% |
32,770
-5,557
| -14% | -$48.8K |
|
5184
Escalade
ESCA
$310M
| $283K | ﹤0.01% |
22,049
-1,846
| -8% | -$24.6K |
|
5185
i3 Verticals
IIIV
$352M
| $283K | ﹤0.01% |
12,329
-210,903
| -94% | -$3.77M |
|
|
EVO
5186
DELISTED
Eaton Vance Ohio Municipal Income Trust
EVO
| $283K | ﹤0.01% |
22,983
-4,145
| -15% | -$52.4K |
|
5187
ProShares Short High Yield
SJB
$47.7M
| $282K | ﹤0.01% |
12,539
-3,249
| -21% | -$74K |
|
5188
Viridian Therapeutics
VRDN
$2.58B
| $282K | ﹤0.01% |
3,367
-322
| -9% | -$30.4K |
|
5189
Gaia
GAIA
$48.1M
| $281K | ﹤0.01% |
18,264
-8,180
| -31% | -$147K |
|
5190
OP Bancorp
OPBK
$233M
| $279K | ﹤0.01% |
24,020
-2,349
| -9% | -$29.4K |
|
|
AGTC
5191
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $279K | ﹤0.01% |
38,195
-6,455
| -14% | -$28.3K |
|
|
AIV.PRA
5192
DELISTED
Apart. Invst and Mgt Co
AIV.PRA
| $279K | ﹤0.01% |
10,799
+300
| +3% | +$7.81K |
|
5193
EVI Industries
EVI
$182M
| $278K | ﹤0.01% |
7,143
-1,391
| -16% | -$58.5K |
|
|
BZM
5194
DELISTED
BlackRock Maryland Municipal Bond Trust
BZM
| $278K | ﹤0.01% |
20,169
-198
| -1% | -$2.75K |
|
|
BGFV
5195
DELISTED
Big 5 Sporting Goods
BGFV
| $276K | ﹤0.01% |
54,103
-345,502
| -86% | -$2.05M |
|
|
GM.WS.B
5196
DELISTED
General Motors Company
GM.WS.B
| $276K | ﹤0.01% |
16,742
+801
| +5% | +$15.5K |
|
|
PINC
5197
DELISTED
Premier
PINC
| $275K | ﹤0.01% |
6,032
-249,501
| -98% | -$10.1M |
|
|
GDP
5198
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $274K | ﹤0.01% |
19,537
-6,035
| -24% | -$78.1K |
|
|
ELGX
5199
DELISTED
Endologix Inc
ELGX
| $274K | ﹤0.01% |
14,396
-4,584
| -24% | -$164K |
|
5200
Gyre Therapeutics
GYRE
$706M
| $273K | ﹤0.01% |
3,386
-1,316
| -28% | -$104K |
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.